MERCK Kommanditgesellschaft auf Aktien Share Price Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 2.13TCr 2.31TCr 1,92500Cr | Sales 2025 * | 2.25TCr 2.44TCr 2,03600Cr | Capitalization | 7.27TCr 7.9TCr 6,58100Cr |
---|---|---|---|---|---|
Net income 2024 * | 295.8Cr 321.46Cr 27TCr | Net income 2025 * | 345.7Cr 375.69Cr 31TCr | EV / Sales 2024 * | 3.8 x |
Net Debt 2024 * | 817.1Cr 887.98Cr 74TCr | Net Debt 2025 * | 506.92Cr 550.9Cr 46TCr | EV / Sales 2025 * | 3.46 x |
P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
20.6
x | Employees | - |
Yield 2024 * |
1.36% | Yield 2025 * |
1.45% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 13/20/13 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/14/01 |
Director of Finance/CFO | 53 | 26/19/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 09/14/09 | |
Christian Raabe
BRD | Director/Board Member | - | - |
Chairman | 67 | 26/19/26 |
1st Jan change | Capi. | |
---|---|---|
+10.23% | 910.95Cr | |
-10.76% | 520.93Cr | |
+51.58% | 483.28Cr | |
+12.50% | 409.46Cr | |
-20.70% | 234.82Cr | |
+12.83% | 231.5Cr | |
+19.51% | 227.39Cr | |
-29.65% | 218.71Cr | |
-0.50% | 164.41Cr |